Tianjin Medical University Cancer Institute and Hospital: all 490 studies
Page 4 of 5. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal MalignanciesActive, not recruitingNCT06997302Not applicable
- Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract CancerActive, not recruitingNCT06717464Phase 2
- Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast CancerStatus unknownNCT06492447
- Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Biopsy Procedure.CompletedNCT06484764Not applicable
- Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular CarcinomaSuspendedNCT06405061Phase 2
- A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC PatientsCompletedNCT06339307
- Single-center, Prospective Study on the Identification and Delineation of Brain and Lung Tumors and At-Risk Organs, and Functional Testing of Surrounding Tissues Based on Dual-Energy CTStatus unknownNCT06301100
- Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT06241079
- The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell CarcinomaCompletedNCT06241066
- Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung CancerCompletedNCT06233396
- Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.CompletedNCT06190652
- A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative SurgeryCompletedNCT06023966
- Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer PatientsCompletedNCT06009627Phase 2/3
- Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II TrialStatus unknownNCT05942573Phase 2
- Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic CancerCompletedNCT05908747Phase 2
- A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast CancerStatus unknownNCT05871918Phase 3
- Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous CarcinomaStatus unknownNCT05854030
- Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side AnastomosisStatus unknownNCT05812495Not applicable
- Tislelizumab Monotherapy or Combined With Lenvatinib as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma.CompletedNCT05807776Phase 2
- A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and VomitingCompletedNCT05792228Not applicable
- Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at RiskCompletedNCT05787522
- The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.Status unknownNCT05781633Not applicable
- Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.CompletedNCT05723978
- Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric CancerStatus unknownNCT05720533Phase 2
- Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.Status unknownNCT05711459Not applicable
- Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phase II Clinical StudyActive, not recruitingNCT05685550Phase 2
- A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular CarcinomaActive, not recruitingNCT05644379Phase 1
- Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard ChemotherapyStatus unknownNCT05627427Phase 2
- Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric CancerStatus unknownNCT05627414Phase 2
- HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular CarcinomaActive, not recruitingNCT05621499Not applicable
- Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.Status unknownNCT05620498Phase 2
- Early Detection of Pancreatic CancerStatus unknownNCT05596435
- Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver MetastasisStatus unknownNCT05524155Phase 2
- Toripalimab-based Neoadjuvant Therapy in LA-HNSCCActive, not recruitingNCT05522985Phase 2
- Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent MutationsStatus unknownNCT05507606Phase 2
- Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung CancerStatus unknownNCT05507593Phase 1
- Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT05476380Phase 2
- Granisetron Transdermal Patch System for Prevention of CINV by CapeOXStatus unknownNCT05325190Phase 2
- Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast CancerStatus unknownNCT05295043Not applicable
- Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative DeliriumCompletedNCT05273827
- Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung CancerStatus unknownNCT05273814Phase 1
- Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R MutationCompletedNCT05263947Phase 2
- Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic CholangiocarcinomaStatus unknownNCT05251662Phase 2
- Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric CancerStatus unknownNCT05228743Not applicable
- Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer PatientsStatus unknownNCT05221775Phase 1
- Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic EsophagectomyStatus unknownNCT05199168Not applicable
- H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World StudyStatus unknownNCT05167643Not applicable
- Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular CarcinomaStatus unknownNCT05166772Phase 2
- Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast CancerStatus unknownNCT05085626Phase 2
- A Study of OLR in First-line Treatment of Mantle Cell LymphomaStatus unknownNCT05076097Phase 2
- Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System.Status unknownNCT05036798Phase 2
- PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal CancerStatus unknownNCT05035381Phase 2
- HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCCStatus unknownNCT05029973Phase 2
- Chemotherapy Combined With Apatinib and PD-1 AntibodyCompletedNCT05025033Phase 2
- Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese MedicineStatus unknownNCT04988165Phase 2
- Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric CancerStatus unknownNCT04982939Phase 2
- Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 MutationsStatus unknownNCT04969029Phase 2
- A One-arm, Prospective Study Comparing the Effects of Different Body Composition on the Survival of Patients Undergoing Radical Concurrent Chemoradiotherapy for Esophageal CancerStatus unknownNCT04936750
- Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerCompletedNCT04903652Phase 2
- Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical CancerStatus unknownNCT04884906Phase 2
- Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung CancerStatus unknownNCT04882033Phase 1
- An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 AntibodyStatus unknownNCT04866381Phase 2
- Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )Status unknownNCT04863079Phase 2
- Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical StudyStatus unknownNCT04842526Phase 2
- Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung CancerActive, not recruitingNCT04836728Phase 2
- SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.CompletedNCT04836520Phase 2
- Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaStatus unknownNCT04834986Phase 2
- Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung CancerStatus unknownNCT04828395Phase 2
- Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard TreatmentsStatus unknownNCT04825925Not applicable
- Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic CancerStatus unknownNCT04814485Phase 2
- Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ AdenocarcinomaStatus unknownNCT04813523Phase 2
- Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic CancerStatus unknownNCT04808687Phase 2
- Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y ReconstructionStatus unknownNCT04801459Not applicable
- Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLCStatus unknownNCT04797806Phase 3
- A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast CancerStatus unknownNCT04767828Phase 4
- Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous TummorStatus unknownNCT04766827Phase 4
- Efficacy and Safety of Sintilimab Combined With Regorafenib and Cetuximab / Sintilimab Combined With Regorafenib in Posterior Line Therapy of Advanced Colorectal Cancer (Regosinti)Status unknownNCT04745130Phase 2
- Prevention and Treatment of Pyrrolitinib-associated DiarrheaStatus unknownNCT04736186Phase 2/3
- A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.Status unknownNCT04733417Phase 2
- Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaCompletedNCT04701060Phase 2
- A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's LymphomaCompletedNCT04696432Phase 1
- Almonertinib With Chemotherapy in mEGFR NSCLCStatus unknownNCT04646824Phase 2
- Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaStatus unknownNCT04631757Phase 2
- Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and ChemotherapyStatus unknownNCT04582955Not applicable
- Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II TrialStatus unknownNCT04553887Phase 2
- Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in ChinaStatus unknownNCT04526028
- Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)Status unknownNCT04389177Phase 2
- Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric CancerCompletedNCT04354662Phase 2
- PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCCStatus unknownNCT04273100Phase 2
- Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric CancerActive, not recruitingNCT04267549Phase 2
- Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.Status unknownNCT04245930Not applicable
- Clinical Application of Nutrition Support Package Before HepatectomyStatus unknownNCT04218253Not applicable
- To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing ChemoradiotherapyCompletedNCT04199832
- Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLCStatus unknownNCT04193098Phase 1
- Mecapegfilgrastim Prevents Neutropenia and Radiation EsophagitisStatus unknownNCT04171986Not applicable
- Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESOStatus unknownNCT04137679Phase 2
- Appatinib Combined With S-1 in the Treatment of Small Cell Lung CancerStatus unknownNCT04128800Phase 2
- Study of SHR-1210 Combined With Apatinib in the Treatment of SarcomaStatus unknownNCT04126993Phase 2
- Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue SarcomaStatus unknownNCT04126811Phase 2
- Ear Acupuncture Preventing Delayed Gastric Emptying.Status unknownNCT04118881Not applicable
← Tianjin Medical University Cancer Institute and Hospital overview and focus areas